University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

Generian Pharmaceuticals, Inc

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Therapeutics

Therapeutic Areas

Immunology

Funding Stage

Series A+

Founders

Toren FinkelBill ChenYuan Liu

Website

https://www.generian.com/
Generian Pharmaceuticals, Inc

Generian Pharmaceuticals is developing oral small-molecule medicines for targets often addressed by biologic drugs. Co-founded by University of Pittsburgh researchers Toren Finkel, Bill Chen and Yuan Liu, the company combines expertise in protein regulation and drug discovery to pursue new treatment options. [1]

Its preclinical pipeline includes inhibitors of FcRn, a protein that helps maintain circulating antibodies, for potential use in antibody-mediated autoimmune disease. Generian is also exploring novel therapeutic targets through a research collaboration with Astellas, expanding its search for medicines that can be taken by mouth. [2]

Discover More with AI